Tasimelteon

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

Tasimelteon

Specification
Cat. No.
SMD1336
Related Diseases
Insomnia
Product Name
Tasimelteon
Size
25.0mg; 50.0mg; 100.0mg; 200.0mg; 500.0mg; 1.0g; Click to view more sizes and prices
Price
Inquiry
Availability
2 Weeks
Description
Tasimelteon (trade name Hetlioz) is a drug approved by the FDA solely for the treatment of non-24-hour sleep–wake disorder (often designated as N24HSWD) in totally blind adults. It is a selective agonist for the melatonin receptors MT1 and MT2 in the suprachiasmatic nucleus of the brain, similar to other members of the melatonin receptor agonist class of which ramelteon (2005) and agomelatine (2009) were the first approved.
CAS Number
609799-22-6
Chemical Formula
C15H19NO2
Exact Mass
245.14158
Molecular Weight
245.32
Elemental Analysis
C, 73.44; H, 7.81; N, 5.71; O, 13.04
Synonym
BMS214778, BMS-214778, BMS 214778, VEC162, VEC-162, VEC 162, Tasimelteon, Hetlioz
IUPAC/Chemical Name
N-(((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide
InChi Key
PTOIAAWZLUQTIO-GXFFZTMASA-N
InChi Code
InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1
SMILES Code
CCC(NC[C@H]1[C@H](C2=C3CCOC3=CC=C2)C1)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO.
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top